By Matt Harrington, BCBA · Behaviorist Book Club · April 2026 · 12 min read

Establishing Consumer Protections for Research in Human Service Agencies: A Practice Guide

Overview & Clinical Significance

The integration of research into clinical practice settings is fundamental to the advancement of applied behavior analysis, yet it raises significant ethical and practical challenges that many agencies are ill-equipped to address. The article by LeBlanc, Nosik, and Petursdottir (2018) in Behavior Analysis in Practice confronted this gap directly by outlining frameworks for establishing consumer protections when research is conducted in human service agencies. This topic carries clinical significance because the quality of the evidence base that guides behavior-analytic practice depends on the integrity and ethical rigor of the research that produces it.

Conducting research in practice settings is the primary mechanism for building the evidence base that behavior analysts rely on for clinical decision-making. Single-case experimental designs, which are the methodological backbone of applied behavior analysis, are inherently conducted within clinical contexts, often with the same clients who are receiving ongoing services. This dual role of research and treatment creates unique ethical tensions that require systematic protections for the individuals who participate.

The clinical significance of establishing consumer protections is multifaceted. For research participants, robust protections ensure that their welfare is prioritized over the researcher's desire for publishable results, that they provide truly informed consent, that the risks and benefits of participation are honestly represented, and that they retain the right to withdraw from research without affecting their access to services. For practitioners, clear guidelines about research protections help them navigate the competing demands of clinical care and research contribution. For the field as a whole, maintaining high ethical standards in practice-based research protects the integrity of the evidence base and public trust in the profession.

Many behavior-analytic agencies are small private practices or community-based organizations that do not have the institutional infrastructure, such as institutional review boards, that universities rely on for research oversight. LeBlanc, Nosik, and Petursdottir (2018) addressed this reality by providing practical guidance on how independent agencies can develop equivalent protections. This is clinically significant because it expands the capacity for practice-based research beyond university-affiliated settings, potentially increasing the volume and ecological validity of behavior-analytic research while maintaining ethical standards.

The clinical significance also extends to the practitioner's professional development. Behavior analysts who understand research ethics are better consumers of research literature, better equipped to evaluate the quality of published studies, and better positioned to contribute to the evidence base through their own practice-based research activities.

Background & Context

The ethical oversight of research involving human participants has a well-documented history shaped by egregious violations of participant welfare. The Nuremberg Code, the Declaration of Helsinki, and the Belmont Report established foundational principles for research ethics: respect for persons, beneficence, and justice. In the United States, the federal Common Rule requires that research involving human subjects conducted at institutions receiving federal funding be reviewed by an institutional review board (IRB) before it begins.

However, many behavior-analytic agencies operate outside the federal regulatory framework because they do not receive federal research funding and are not affiliated with universities that maintain IRBs. This creates a gap in research oversight that affects a significant portion of practice-based behavioral research. Individual practitioners conducting research within their own clinical caseloads may have no external review mechanism to evaluate the ethical implications of their research activities.

LeBlanc, Nosik, and Petursdottir (2018) positioned their work within this gap, arguing that the absence of regulatory requirements does not eliminate the ethical obligation to protect research participants. They drew on the principles articulated in the Belmont Report and the practical structures of IRB review to propose models for research oversight that can be implemented in agencies of varying sizes and resources.

The background for this topic also includes the unique characteristics of behavior-analytic research that create particular ethical considerations. Single-case experimental designs often require manipulation of treatment conditions, including baseline or reversal phases where effective treatment may be temporarily withheld or modified. Participants in behavior-analytic research are frequently individuals with disabilities or other vulnerable characteristics who may have limited capacity to provide fully informed consent. And the dual relationship between researcher and clinician creates potential conflicts of interest that require careful management.

The context also includes the growing emphasis on practice-based evidence in behavior analysis and related fields. There is increasing recognition that research conducted in controlled university settings may not fully represent the conditions under which behavior-analytic services are typically delivered. Practice-based research has the advantage of ecological validity but the challenge of ensuring that ethical standards are maintained without the institutional infrastructure that university settings provide.

The BACB has addressed research ethics through its Ethics Code, with specific standards governing research activities. However, the Ethics Code provides principles rather than detailed procedural guidance, leaving agencies to determine how to operationalize those principles in their specific contexts.

Clinical Implications

The clinical implications of establishing consumer protections for practice-based research affect researchers, clinicians, agency administrators, and the clients and families who may be invited to participate in research activities.

For practitioners who conduct research within their clinical practice, the most significant implication is the need to separate research activities from clinical care in their own thinking and in their communication with clients. When a practitioner develops a novel intervention approach and wants to evaluate its effectiveness through a systematic replication, they transition from purely clinical activity to research activity. This transition triggers ethical obligations related to research protections that may exceed the obligations associated with routine clinical practice. The distinction is not always clear-cut, and one of the practical challenges agencies face is determining when a clinical innovation crosses the line into research that requires formal oversight.

The clinical implications also include the informed consent process. Consent for research participation must be distinct from and more detailed than consent for clinical services. Research consent must explain the specific research questions being investigated, the procedures that will be used, the potential risks and benefits of participation, the participant's right to withdraw without affecting their access to clinical services, how data will be used and shared, and any potential conflicts of interest the researcher may have. Code 5.04 (Informed Consent in Research) addresses these requirements specifically.

For agency administrators, the implications involve developing and maintaining infrastructure for research oversight. This may include establishing an internal review committee, developing relationships with external review resources, creating policies and procedures for research approval, and training staff on research ethics. The investment required varies based on the agency's size and research activity, but some form of structured oversight is ethically necessary whenever research is conducted.

The clinical implications extend to the protection of clients who may feel pressure to participate in research. In practice settings, clients and families often have ongoing relationships with their clinicians and may feel obligated to agree to research participation to maintain those relationships. Code 5.05 (Confidentiality in Research) and Code 5.03 (Research in Service Delivery) address aspects of this concern, but the practical challenge of ensuring truly voluntary consent in the context of a clinical relationship requires deliberate safeguards such as having someone other than the treating clinician obtain research consent.

There are also implications for the dissemination of practice-based research. When agencies establish robust consumer protections, they increase the credibility and publishability of their research. Peer-reviewed journals increasingly require evidence of ethical oversight for submitted research, and agencies that cannot demonstrate such oversight may find their contributions to the literature rejected regardless of the quality of their data.

Ethical Considerations

The ethical considerations for research in human service agencies are governed by the BACB Ethics Code (2022) Section 5 (Responsibility in Research), which provides specific guidance on the conduct of behavior-analytic research.

Code 5.01 (Conforming with Laws and Regulations) requires that behavior analysts comply with all applicable laws and regulations governing research with human participants. While many practice-based researchers may not be subject to federal Common Rule requirements, state regulations, professional licensing board rules, and organizational policies may impose research oversight requirements. Behavior analysts must determine which regulations apply to their specific situation and comply fully.

Code 5.02 (Research Review) is directly relevant to the topic of consumer protections. This standard requires behavior analysts to seek appropriate review of their research activities. In university settings, this review is provided by IRBs. In independent practice settings, LeBlanc, Nosik, and Petursdottir (2018) proposed alternative models including internal review committees, external review partnerships, and consultation with individuals with research ethics expertise. The key principle is that research should not be conducted without some form of independent review, regardless of the setting.

Code 5.03 (Research in Service Delivery) addresses the unique challenges of conducting research within the context of ongoing clinical services. This standard requires that research activities not compromise the quality of clinical care, that participants have access to effective treatment regardless of their research participation decisions, and that the dual role of researcher and clinician be managed transparently. This standard has particular significance for practice-based research where the researcher is often the same person providing clinical services.

Code 5.04 (Informed Consent in Research) requires that participants or their legally authorized representatives provide voluntary informed consent before participating in research. The consent process must include a clear explanation of the research purpose, procedures, potential risks and benefits, the right to decline or withdraw without penalty, and how data will be used. For individuals with limited capacity to consent, the behavior analyst must obtain consent from an appropriate surrogate while also obtaining the individual's assent to the extent possible.

Code 5.05 (Confidentiality in Research) requires that research data be handled in a manner that protects participant privacy. This includes secure data storage, de-identification of published data, and clear policies about who has access to research records.

Code 5.06 (Publishing Research) addresses the behavior analyst's responsibility to report research results accurately and to give appropriate credit to contributors. This standard also requires that behavior analysts correct errors in published work promptly when discovered.

Beyond the specific research ethics standards, the broader ethical principles of beneficence (maximizing benefit and minimizing harm), respect for persons (treating individuals as autonomous agents and protecting those with diminished autonomy), and justice (fair distribution of research burdens and benefits) should guide all research activities in human service agencies.

Assessment & Decision-Making

Assessment and decision-making in the context of establishing consumer protections for research involve evaluating the agency's current research activities, determining the level of oversight needed, and selecting an appropriate model for research review.

The first assessment involves identifying what constitutes research within the agency's activities. This distinction can be challenging because many activities in behavior-analytic practice have both clinical and research components. Routine clinical activities such as conducting functional analyses, implementing evidence-based interventions, and collecting treatment data are standard clinical practice and do not typically require research oversight. However, when a practitioner systematically manipulates variables to test a hypothesis, plans to disseminate the findings beyond the agency, or implements procedures that deviate from standard clinical care for the purpose of generating generalizable knowledge, the activity moves into the research domain.

The second assessment involves evaluating the agency's current protections. Questions to ask include: Does the agency have any formal research review process? Who is responsible for ensuring that research activities comply with ethical standards? How is informed consent for research obtained, and how does it differ from clinical consent? What safeguards exist to protect participants from coercion, particularly when the researcher is also their clinician? How is research data stored, de-identified, and shared?

Decision-making about the appropriate model for research oversight depends on the agency's size, resources, and research activity level. LeBlanc, Nosik, and Petursdottir (2018) described several models that agencies can consider. A full internal review committee, modeled after a university IRB, may be appropriate for large agencies with active research programs. Smaller agencies might establish a partnership with a university IRB that agrees to review their protocols, or they might engage an independent ethics consultant to provide review services. At minimum, agencies should designate a qualified individual who is responsible for reviewing all research activities for ethical compliance before they begin.

Decision-making should also address the specific protections needed for the agency's research participant population. If the agency primarily serves children with developmental disabilities, the protections must account for the participants' limited capacity to consent, the potential for coercion of parents who may feel obligated to agree to research to maintain their child's services, and the particular vulnerability of this population to research-related risks.

The assessment process should include consultation with individuals who have expertise in research ethics. Many behavior analysts receive limited training in research ethics during their graduate programs, and the practical challenges of implementing research protections in community-based settings may exceed their existing knowledge. Consulting with bioethicists, experienced researchers, or professionals who serve on IRBs can provide valuable guidance for agencies developing their research oversight infrastructure.

Finally, agencies should assess their research protections on an ongoing basis rather than treating the establishment of a review process as a one-time event. Regular audits of research activities, participant feedback mechanisms, and periodic review of policies and procedures ensure that protections remain robust and responsive to changing circumstances.

What This Means for Your Practice

Whether you are a solo practitioner considering a clinical case study or an agency director overseeing a research program, establishing consumer protections for practice-based research is both an ethical obligation and a professional investment.

If you conduct any research in your practice, no matter how informal, develop a process for independent review before the research begins. This might be as simple as asking a colleague with research ethics training to review your protocol and consent documents, or as formal as establishing an internal review committee. The level of oversight should be proportional to the complexity and risk of the research, but some form of independent review is ethically necessary for all research activities.

Develop research consent documents that are distinct from your clinical consent forms. These documents should clearly explain the research purpose, the specific procedures involved, any potential risks, the participant's right to withdraw without affecting their clinical services, and how their data will be used. Have these documents reviewed by someone with research ethics expertise.

Create safeguards against coercion. When possible, have someone other than the treating clinician discuss research participation with potential participants. Ensure that participants understand, through both written and verbal communication, that declining to participate will have no effect on their access to services or the quality of care they receive.

Invest in your own research ethics education. The BACB Ethics Code provides foundational guidance, but the practical challenges of implementing research protections in community-based settings require knowledge that goes beyond what most graduate programs provide. Seek out continuing education in research ethics, consult with experienced researchers, and stay current with developments in this area.

By establishing robust consumer protections, you not only fulfill your ethical obligations but also enhance the quality and credibility of your research contributions to the field.